Related Experiment Videos
Microtubule-interacting drugs for cancer treatment
Paula M Checchi1, James H Nettles, Jun Zhou
1Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. pchecch@emory.edu
Trends in Pharmacological Sciences
|July 23, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo.
Journal of experimental & clinical cancer research : CR·2020
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor.
ACS medicinal chemistry letters·2019
The Use of 15 N NMR Spectroscopy To Resolve the "Higher Order Cyanocuprate" Controversy: 15 N, 6 Li, and 13 C NMR Spectroscopic Investigations of CuCN-Derived Butyl Cuprates.
Angewandte Chemie (International ed. in English)·2018
Substrates and Inhibitors of SAMHD1.
PloS one·2017
Nitroxyl (HNO) therapeutics: exposure control and target engagement.
Trends in pharmacological sciences·2026
Emerging STAT1 post-translational modifications: mechanisms and translational perspectives.
Trends in pharmacological sciences·2026
The expanding role of Cav3 channels in glioblastoma.
Trends in pharmacological sciences·2026
Why pharmacological concepts survive despite scientific progress.
Trends in pharmacological sciences·2026
Dissecting the Lewy body.
Trends in pharmacological sciences·2026
De-Nterm-ining GLP1R signaling bias.
Trends in pharmacological sciences·2026
AR/PARP Dual-Targeting Bioactive Photosensitizer for Photo-Immunotherapy of Prostate Cancer.
Advanced materials (Deerfield Beach, Fla.)·2026
A Systems View of Posterior Capsule Opacification: TGF-β/ROS Signaling, Mitochondrial Homeostasis, and Injury/Aging Cues-Therapeutic Opportunities.
Investigative ophthalmology & visual science·2026
(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.
Journal of the National Cancer Institute·2026
LINC01871-Mediated Sensitivity to Cyclin-Dependent Kinase 4/6 Inhibitors in Human Breast Cancer.
Journal of visualized experiments : JoVE·2026